INDUCTION OF OVULATION IN THE HUMAN WITH
GONADOTRO-PINS.* By C. Lee Buxton and Walter Herrmann, Department of Obstetrics and Gynecology, Yale University School of Medicine. During the 33 years since human chorionic gonadotropin (hereafter to be designated as HCG) was shown to produce ovulation in small mammals, there have been numerous unsatisfactory attempts to stimulate human ovarian activity by various gonadotropin extracts.2 Recent evidence of successful species specific gonadotropin extract administration in the monkey and human has been presented by van Wagenen and Simpson8 and by Gemzell.' The extract used by injection in the present series (HPG) ** was obtained from human autopsy material, regardless of the age or sex of the subject. YALE JOURNAL OF BIOLOGY AND MEDICINE present therapy, particularly in patients suffering from hypothalamic amenorrhea, it was felt that the present design would control this aspect and also eliminate HCG alone as the substance responsible for ovulation, should this occur. The patients were evaluated by the means of basal body temperature charts, endometrial biopsies, vaginal smears, and in one case by culdoscopy. They have all been amenorrheic, either primarily or from three to six years. They had various diagnoses, as designated in Figure 1 , and all had had thorough endocrine investigations. As is seen in Figure 2 , one patient (A.R.) after three years of amenorrhea, ovulated and menstruated following each of the two courses of HCG alone and, as a matter of fact, has continued to menstruate and ovulate since, a result quite different from all of the others. The remaining patients failed to ovulate or menstruate following HCG therapy alone and they therefore were considered appropriate cases to be treated with the combination of HPG and HCG, using a technique and dosage schedule as originally designed by van The results are apparent in Figure 2 . The presence of ovulation was established by the typical changes in the basal body temperature, as well as by secretory transformation of the endometrium. In one patient (A.P.) formerly diagnosed as anorexia nervosa, further documentation was obtained through direct inspection of the ovaries by culdoscopy. This disclosed an enlargement of the ovaries to what was judged to be about three times the normal size, with at least three areas observed in each ovary that were raised above the surface; three were about 1 cm. in diameter and dark purplish or bluish in color, each having at the apex a hemorrhagic stoma. This latter finding is quite similar to the observation of van Wagenen and Simpson in the monkey and of Gemzell in the human.
In summary, seven amenorrheic women were given 15 series of injections of human pituitary material, consisting of human pituitary extract (HPG) combined in part with chorionic gonadotropin (HCG). There were two failures of therapy; one was a patient diagnosed as congenital adrenal hyperplasia, age 33, who had had, at the age of 11, a resection of ovarian tissue and subsequent prolonged treatment with various steriods, primarily of the cortisone series. The other patient responded to the therapy by uterine bleeding, but without evidence of ovulation. She was diagnosed as a ChiariFrommel syndrome (amenorrhea, galactorrhea, low estrogen). However, she did not receive the full course of therapy, which had proved to be successful in subsequent cases. The other patients, amenorrheic primarily, or for from three to six years, responded to therapy by uterine bleeding from secretory endometrium and had basal body temperature charts characteristic of progestational activity. It was therefore assumed that they had ovulated. One patient, who was subjected to culdoscopy, appeared to have at least three ovulation points in each ovary. These findings are in agreement with the experiments of van Wagenen and Simpson in Macaca mulatta and of Gemzell in the human.
